Does Massive Bowel Resection in Newborns Affect Further Immunity in Children?
Level 4 - case-series / case-control
Small observational case-control study.
PubMed 38255427 · doi:10.3390/children11010114
What was done
Researchers evaluated adaptive immune parameters in 15 children who underwent massive small bowel resection in their first months of life and required home parenteral nutrition. Using flow cytometry, peripheral blood lymphocyte subsets (T, B, NK, CD4+, CD8+, and activated T cells) and serum immunoglobulins were assessed and compared against a control group.
What was found
The abstract reports statistically significant differences in the proportions of B, T, CD8+, and NK cells between groups, along with a significantly lower absolute count of NK cells in the short bowel syndrome (SBS) group relative to controls. In the SBS group, absolute counts of total lymphocytes, B, T, and CD4+ cells, as well as percentages of CD4+ and activated T cells, were inversely correlated with patient age. Specific numerical values, effect sizes, and p-values were not provided in the abstract.
Why it matters
Massive resection removes significant gut-associated lymphoid tissue, raising concerns about systemic immune compromise. These findings suggest that while laboratory shifts in lymphocyte subpopulations and lower NK cell counts occur, affected children do not appear to develop overt clinical immunodeficiency.
Limits
The study is limited by a very small sample size (n = 15 SBS patients), an unspecified control group size in the abstract, and lack of reported exact numeric data or statistical values. Long-term functional immune responses to pathogens or vaccines were not detailed.
Cited by
- supports The human gut contains more immune cells than any other part of the body.